‘Psychedelics are the next yoga’ — This Billionaire’s Son is Pioneering the Psychedelic Wellness Revolution
In a bold pivot from traditional wellness practices, JJ Wilson, the visionary eldest son of Lululemon’s billionaire founder Chip Wilson, is setting new benchmarks in the health sector with his groundbreaking venture, Optimi Health. This innovative company, which he co-founded in 2021, is at the forefront of producing pharmaceutical-grade psychedelics, aiming to transform mental health treatment worldwide.
Read more on this story at The Daily Beast.
With an initial investment surpassing $2 million from each of the co-founders and an additional $10 million through financing rounds, Optimi Health is on the cusp of obtaining a prestigious Health Canada license. This certification will enable the company to supply naturally sourced psilocybin and synthetic MDMA to authorized medical markets globally.
Wilson, currently engaged in a 30-day mushroom microdose regimen, shared his insights during a casual meeting at a local bistro in Vancouver, Canada.
He advocates for the therapeutic benefits of microdosing, which he believes can elevate personal well-being and focus.
“Recreational therapeutic treatment can make good people great,” Wilson remarked, envisioning a future where daily microdosing could become as routine as taking vitamins.
Optimi Health’s product line includes unique formulations that blend psychoactive compounds like psilocybin with non-psychoactive mushrooms such as reishi and lion’s mane. These adaptogens are reputed to support cognitive health and potentially slow neurodegenerative diseases, offering a natural alternative to conventional antidepressants. There’s talk among the medical community about some psychiatrists already prescribing these microdoses discreetly.
New: Interested in Being Part of a Psychedelics-Focused Clinical Trial? Sign Up Here
Wilson draws a parallel between the integration of psychedelics into mainstream wellness and the rise of yoga in the West. He believes that just as yoga introduced Westerners to meditation and a break from technology-driven lifestyles, psychedelics will further this wellness revolution.
“Psychedelics are the next yoga,” he asserts, emphasizing the role of these substances in optimizing life and health.
During several guided psilocybin sessions, Wilson explored personal growth areas. Particularly in improving relationships and overcoming resentment towards various people in his life. These experiences, he notes, have significantly enhanced his happiness and overall mental clarity.
Support from his father, Chip Wilson, has been instrumental. Chip recently praised Optimi Health’s potential to globally scale the commercialization of psychedelics after visiting their headquarters in Princeton, a tranquil mountain town a few hours from Vancouver. JJ Wilson appreciates his family’s backing in his entrepreneurial pursuits, highlighting a collaborative spirit in various projects.
Optimi Health isn’t just about business for Wilson; it’s about pioneering a new approach to wellness and therapy. The company’s state-of-the-art facility in Princeton boasts one of the world’s largest legal psychedelic mushroom farms. And is a testament to their commitment to quality and safety. Here, over 200 kg of psychedelic mushrooms and 1,000 doses of pure MDMA are meticulously produced under stringent conditions, mirroring the pharmaceutical industry’s high standards.
The global market for legal psychedelics is poised for significant growth, with projections suggesting it could reach nearly $11 billion by 2027.
This surge is supported by a growing body of research that underscores the potential of psychedelics to effectively address mental health and addiction issues.
Despite the promising outlook, the path forward for psychedelics in medicine involves careful consideration of safety and ethical standards, especially as these powerful substances become more accessible in therapeutic settings. Optimi Health is at the forefront of addressing these challenges, ensuring that their products not only meet but exceed current medical and safety standards.
Wilson remains cautiously optimistic about the future, focusing on solidifying Optimi’s foundation before publicizing their achievements too widely. “I’m very much, don’t talk about it till it’s ready,” he states, underscoring a strategic approach to growth and innovation.
